View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . July 28th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Cedars-Sinai Medical Center - New protocol streamlines therapy that makes more kidney transplants possible

Adverse Drug Reactions - Cardiome Announces Positive Phase 2b Results for Oral Vernakalant

Asthma - MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion

Breast Cancer - Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008

Cyclacel Pharmaceuticals, Inc. - Cyclacel Publishes Study of Seliciclib Synergy with Tarceva and Herceptin in Journal Clinical Cancer Research

Prostate Cancer - OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011

Adenocarcinoma - Recent studies from Baylor University add new data to adenocarcinoma

Apoptosis - New research on apoptosis from P. Revill and co-authors summarized

Breast Cancer - Scientists at Catholic University target breast cancer

Cancer - Research conducted at N.M.G.M. Appels and co-researchers has updated our knowledge about cancer

Cancer Vaccines - Research results from R. Harrop and co-authors update knowledge of cancer vaccines

Carcinoma - Researchers from Yonsei University report recent findings in carcinoma

Clostridium - Research data from J. Peppe and colleagues update understanding of clostridium

Deep Vein Thrombosis - Findings from Sahlgrenska University broaden understanding of deep vein thrombosis

Gene Therapy - Data on gene therapy detailed by J.L. Eberling and co-authors

Heart Failure - Investigators at National Institutes of Health zero in on medicinal chemistry

HIV/AIDS - New research on HIV/AIDS from N. Teleshova and co-authors summarized

Kidney Cancer - Studies by R.J. Amato and co-authors describe new findings in kidney cancer

Life Sciences - Investigators at GlaxoSmithKline, Collegeville release new data on life sciences

Lymphoma - Data on lymphoma reported by A. Hagenbeek and co-researchers

Melanoma - Research conducted at P. Hersey and co-authors has provided new information about melanoma

Pharmacokinetics - Research conducted at R. Jordan and co-researchers has updated our knowledge about pharmacokinetics

Rectal Cancer - New research on rectal cancer from University of Colorado summarized

Renal Cell Carcinoma - New renal cell carcinoma study findings have been published by R.J. Amato and colleagues

Solid Cancer - University of Zurich publishes research in solid cancer

Vasculitis - Study findings from Northwestern University, Medical Department provide new insights into vasculitis

Arthritis Clinical Trial - Reports outline arthritis clinical trial research from University of Amsterdam

Cancer Clinical Trial - Findings from Newcastle General Hospital provide new insights into cancer clinical trial

Cancer Clinical Trial - New cancer clinical trial study findings reported from Center for Cancer Research

Cancer Therapy - Studies from Abbott Laboratories provide new data on cancer therapy

Cancer Therapy - Studies from Center for Cancer Research reveal new findings on cancer therapy

Cancer Therapy - Study findings from M.D. Anderson Cancer Center provide new insights into cancer therapy

Chromatography - Studies by B. Di and co-authors describe new findings in chromatography

Clinical Trial Research - New clinical trial research study results from National Institutes of Health described

Colon Cancer Immunotherapy - Data from Siena University, Medical Oncology Department advance knowledge in colon cancer immunotherapy

Depression Therapy - Reports outline depression therapy research from George Washington University, Research Center

Leukemia Gene Therapy - Research on leukemia gene therapy described by scientists at Ohio State University

Life Sciences - Data on life sciences discussed by researchers at National Institute of Animal Health

Non-Small Cell Lung Cancer Therapy - Findings from Vall d'Hebron University broaden understanding of non-small cell lung cancer therapy

Amgen - Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy

Amgen Inc. - FDA Approves Nplate for Long-Term Treatment of Adult Chronic ITP

Biotech Business - CSCS DVC Wins $32.3 Million NIAID Contract to Establish Phase 1 Clinical Trial Unit

Calistoga Pharmaceuticals, Inc. - Calistoga Pharmaceuticals Initiates First Oncology Clinical Trial of Novel PI3K Delta Inhibitor, CAL-101

Cancer Vaccines - Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC

Chronic Lymphocytic Leukemia - FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia

Clinical Trial Research - CSC's DVC Wins $32.3 Million NIAID Contract to Establish Phase 1 Clinical Trial Unit

Cortria Corporation - Cortria Corporation Announces Appointment of Daniel Grau as CEO & Vice-Chairman and Richard King as Director

Cystic Fibrosis - PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124

Diarrhea - Optimer Pharmaceuticals Announces Positive Results in Prulifloxacin Phase 3 Study

DNA Vaccines - Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines

Drug Delivery - EyeGate Pharma Initiates Landmark Clinical Study Employing the EyeGate(R) II Non-Invasive Ocular Delivery System in Acute Anterior Uveitis

Dyax Corp. - Dyax Enters into an Exclusive Negotiation Period with Dompe for European License to DX-88 in Angioedema Indications

Endometriosis - Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis

Gamida Cell Ltd. - Gamida Cell Signs Collaboration Agreement With Biologics Delivery Systems

Glioblastoma - Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials

Headache and Migraine - MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine

Immunization - Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data

Interspace Airport Advertising - Interspace Airport Advertising Brings Digital Advertising to New Terminal at Raleigh-Durham International Airport

Liver Disease - Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease

Multiple Sclerosis - Peptimmune Announces the Second Close of Series D Private Financing

Neurogen Corporation - Neurogen Announces Suspension of Insomnia Study with Adipiplon

Non-Hodgkin Lymphoma - Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma

Non-Small Cell Lung Cancer - BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial

Nymox Pharmaceutical Corporation - BPH: a Major Challenge for Men's Healthcare

Obesity and Diabetes - Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.

OSI Pharmaceuticals, Inc. - OSI Pharmaceuticals Begins Clinical Development Program for OSI-027 in Patients with Advanced Solid Tumors or Lymphoma

Prostate Cancer - Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery

Repros Therapeutics Inc. - Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain in a U.S. Phase 2 Clinical Trial in Women with Moderate to Severe Endometriosis

Surgery - Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery

Vical Incorporated - Vical to Present Phase 1 Data for Vaxfectin-Formulated Pandemic Influenza DNA Vaccines

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx